Search Results

Summary This antibody recognize D-dimer and high molecular weight fibrin degradation products. It does not cross-react with fibrinogen.

Summary Reacts equally with free cardiac troponin I (cTnl) and cTnI forming complexes with other troponincomponents (in the presence of 5 mM EDTA). Not affected by heparin, phosphorylation and oxidation.Recognizes an epitope located between amino acid residues 169 and 178 of cTnI. No cross-reactivity withskeletal muscle troponin I.

Summary Reacts equally with free cardiac troponin I (cTnl) and cTnl forming complexes with other troponincomponents. Not effected by heparin, phosphorylation and oxidation. Recognizes an epitope locatedbetween amino acid residues 83 and 93 of cTnI. No cross reactivity with skeletal muscle troponin I.

Summary Reacts with free cardiac troponin I (cTnI) and cTnI forming complexes with other troponin components. Not affectedby heparin and phosphorylation. Recognizes an epitope located between amino acid residues 1 and 15 of cTnI. Nocross-reactivity with skeletal muscle troponin I.

Summary Species Specific: Extremely low recognition of human Apo E. No data available regarding rat activity.

Summary The basic IGF-1-like forms (pI>9.0) showed substantial cross-reactivity, as did rat and mouse sera.Monoclonal antibody BM23 was capable of abolishing the biological activities of IGF-1 in-vitro bioassaysfor insulin-like, mitogenic and sulphation activities.

Summary This antibody recognizes the long and short forms CD158a and CD158b (KIR2DL, KIR2DS1 and KIR2DS2 respectively) and also p50.3 (KIR2DS4).